Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2002 Nov 12;32(2):111–138. doi: 10.1016/0168-1702(94)90038-8

The immunopathogenesis of equine infectious anemia virus

Debra C Sellon 1,∗, Frederick J Fuller 1, Travis C McGuire 1
PMCID: PMC7134051  PMID: 8067050

The content is available as a PDF (2.3 MB).

References

  1. Archer B.G., Crawford T.B., McGuire T.C., Frazier M.E. RNA-dependent DNA polymerase associated with equine inefectious anemia virus. J. Virol. 1977;22:16–22. doi: 10.1128/jvi.22.1.16-22.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ball J.M., Payne S.L., Issel C.J., Montelaro R.C. EIAV genomic organizaiton; further characterization by sequencing of purified glycoproteins and cDNA. Virology. 1988;165:601–605. doi: 10.1016/0042-6822(88)90605-8. [DOI] [PubMed] [Google Scholar]
  3. Banks K.L. Monocyte activation in horses persistently infected with equine infectious anemia virus. Inf. Immun. 1975;12:1219–1221. doi: 10.1128/iai.12.5.1219-1221.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Banks K.L., Henson J.B. Quantitation of immunoglobulin-bearing lymphocytes and lymphocyte response to mitogens in horses persistently infected by equine infectious anemia virus. Inf. Immun. 1973;8:679–682. doi: 10.1128/iai.8.4.679-682.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Banks K.L., Henson J.B., McGuire T.C. Immunologically mediated glomerulitis of horses I. Pathogenesis in persistent infection by equine infectious anemia virus. Lab. Invest. 1972;26:701–707. [PubMed] [Google Scholar]
  6. Beisel C.E., Edwards J.F., Dunn L.L., Rice N.R. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J. Virol. 1993;67:832–842. doi: 10.1128/jvi.67.2.832-842.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Benton C.V., Brown B.L., Harshman J.S., Gilden R.V. In vitro host range of equine infectious anemia virus. Intervirology. 1981;16:225–232. doi: 10.1159/000149271. [DOI] [PubMed] [Google Scholar]
  8. Burns S.J. Equine infectious anemia: plasma clearance times of passively transferred antibody in foals. J. Am. Vet. Med. Assoc. 1974;164:64–65. [PubMed] [Google Scholar]
  9. Burstin S.J., Brandriss M.W., Schlesinger J.J. Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth. J. Immunol. 1983;130:2915–2919. [PubMed] [Google Scholar]
  10. Cardosa M.J., Porterfield J.S., Gordon S. Complement receptor mediates enhanced flavivirus replication in macrophages. J. Exp. Med. 1983;158:258–263. doi: 10.1084/jem.158.1.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cardosa M.J., Gordon S., Hirsch S., Springer T.A., Porterfield J.S. Interaction of West Nile virus with primary murine macrophages: role of cell activation adn receptors for antibody and complement. J. Virol. 1986;57:952–959. doi: 10.1128/jvi.57.3.952-959.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carpenter S., Evans L.H., Sevoian M., Chesebro B. Role of the host immune response in selection of equine infectious anemia virus variants. J. Virol. 1987;61:3783–3789. doi: 10.1128/jvi.61.12.3783-3789.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Carpenter S., Alexandersen S., Long M.J., Perryman S., Chesebro B. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. J. Virol. 1991;65:1605–1610. doi: 10.1128/jvi.65.3.1605-1610.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Carpenter S., Chesebro B. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J. Virol. 1989;63:2492–2496. doi: 10.1128/jvi.63.6.2492-2496.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Carre H., Vallee H. Sur panemic infectieuse du cheval. Compt. Rend. Acad. Sci. (Paris) 1904;139:331. [Google Scholar]
  16. Carre H., Vallee H. Sur panemic infectieuse du cheval. Compt. Rend. Acad. Sci. (Paris) 1904;139:1239. [Google Scholar]
  17. Carre H., Vallee H. Recherches cliniques et experimentales sur panemie pernicieuse du cheval. Rev. Gen. Med. Vet. 1906;8:593. [Google Scholar]
  18. Carroll R., Martarano L., Derse D. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J. Virol. 1991;65:3460–3467. doi: 10.1128/jvi.65.7.3460-3467.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Carvalho M., Derse D. Mutational analysis of the equine infectious anemia virus tat-responsive element. J. Virol. 1991;65:3468–3474. doi: 10.1128/jvi.65.7.3468-3474.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Carvalho M., Derse D. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter. J. Virol. 1993;67:2065–2074. doi: 10.1128/jvi.67.4.2064-2074.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cecilia D., Gadkari D.A., Kedarnath N., Ghosh S.N. Epitope mapping of Japanese encephalitis virus envelope protein using monoclonal antibodies against an Indian strain. J. Gen. Virol. 1988;69:2741–2747. doi: 10.1099/0022-1317-69-11-2741. [DOI] [PubMed] [Google Scholar]
  22. Chanas A.C., Gould E.A., Clegg J.C.S., Varma M.G.R. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J. Gen. Virol. 1982;58:37–46. doi: 10.1099/0022-1317-58-1-37. [DOI] [PubMed] [Google Scholar]
  23. Charman H.P., Bladen S., Gilden R.V., Coggins L. Equine infectious anemia virus: evidence favoring classification as a retravirus. J. Virol. 1976;19:1073–1079. doi: 10.1128/jvi.19.3.1073-1079.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Charman H., Long C., Coggins L. Specificity of response to viral proteins in horses infected with equine infectious anemia virus. Inf. Immun. 1979;23:472–478. doi: 10.1128/iai.23.2.472-478.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Cheevers W.P., Archer B.G., Crawford T.B. Characterization of RNA from equine infectious anemia virus. J. Virol. 1977;24:489–497. doi: 10.1128/jvi.24.2.489-497.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cheevers W.P., McGuire T.C. Equine infectious anemia virus: immunopathogenesis and persistence. Rev. Inf. Dis. 1985;7:83–88. doi: 10.1093/clinids/7.1.83. [DOI] [PubMed] [Google Scholar]
  27. Chong Y.H., Payne S.L., Issel C.J., Montelaro R.C., Rushlow K.E. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus. J. Virol. 1991;65:1007–1012. doi: 10.1128/jvi.65.2.1007-1012.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Chong Y.H., Ball J.M., Issel C.J., Montelaro R.C., Rushlow K.E. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J. Virol. 1991;65:1013–1018. doi: 10.1128/jvi.65.2.1013-1018.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Clabough D.L., Gebhard D., Flaherty M.T., Whetter L.E., Perry S.T., Coggins L., Fuller F.J. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus. J. Virol. 1991;65:6242–6251. doi: 10.1128/jvi.65.11.6242-6251.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Clabough D.L. Equine infectious anemia: the clinical signs, transmission, and diagnostic procedures. Vet. Med. 1990:1007–1019. [Google Scholar]
  31. Clavel F., Hoggan M.D., Willey R.L., Strebel K., Martin M.A., Repaske R. Genetic recombination of human immunodeficiency virus. J. Virol. 1989;63:1455–1459. doi: 10.1128/jvi.63.3.1455-1459.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Coggins L., Norcross N.L. Immunodiffusion reaction in equine infectious anemia. Cornell Vet. 1970;60:330–335. [PubMed] [Google Scholar]
  33. Coggins L., Norcross N.L., Nusbaum S.R. Diagnosis of equine infectious anemia by immunodiffusion test. Am. J. Vet. Res. 1972;33:11–18. [PubMed] [Google Scholar]
  34. Crawford T.B., McGuire T.C., Henson J.B. Detection of equine infectious anemia virus in vitro by immunofluorescence. Arch. Gesamte Virusforsch. 1971;34:332–339. doi: 10.1007/BF01242979. [DOI] [PubMed] [Google Scholar]
  35. Crawford T.B., Wardrop K.J., Reliich E., Meyers K.M., Tornquist S.J., McGuire T.C. 1993. A Primary production deficit in the thrombocytopenia of equine infectious anema. in preparation. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Daughaday C.C., Brandt W.E., McCown J.M., Russell P.K. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Inf. Immun. 1981;32:469–473. doi: 10.1128/iai.32.2.469-473.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Derse D., Carroll R., Carvalho M. Transcriptional regulation of equine infectious anemia virus. Sem. Virol. 1993;4:61–68. [Google Scholar]
  38. Derse D., Dorn P.L., Levy L., Stephens R.M., Rice N.R., Casey J.W. Characterization of equine infectious anemia virus long terminal repeat. J. Virol. 1987;61:743–747. doi: 10.1128/jvi.61.3.743-747.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Dorn P.L., Derse D. cis- and trans-acting regulation of gene expression of equine infectious anemia virus. J. Virol. 1988;62:3522–3526. doi: 10.1128/jvi.62.9.3522-3526.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Dorn P.L., DaSilva L., Martarano L., Derse D. Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J. Virol. 1990;64:1616–1624. doi: 10.1128/jvi.64.4.1616-1624.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Dougherty J.P., Temin H.M. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J. Virol. 1988;62:2817–2822. doi: 10.1128/jvi.62.8.2817-2822.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Egberink H.F., Ederveen J., Montelaro R.C., Pedersen N.C., Horzinek M.C., Koolen M.J.M. Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. J. Gen. Virol. 1990;71:739–743. doi: 10.1099/0022-1317-71-3-739. [DOI] [PubMed] [Google Scholar]
  43. Evans K.S., Carpenter S.L., Sevoian M. Detection of equine infectious anemia virus in horse leukocyte cultures derived from horses in various stages of equine infectious anemia viral infection. Am. J. Vet. Res. 1984;45:20–25. [PubMed] [Google Scholar]
  44. Foil L.D., Adams W.V., McManus J.M., Issel C.J. Quantifying the role of horseflies as vectors of equine infectious anemia. In: Powell D.G., editor. Equine Infectious Diseases V. Proceedings of the Fifth International Conference. University Press of Kentucky; Lexington, KY: 1988. pp. 189–195. [Google Scholar]
  45. Foil L.D. A mark-recapture method for measuring effects of spatial separation of horses on tabanid (Diptera) movement between hosts. J. Med. Entomol. 1983;20:301–305. doi: 10.1093/jmedent/20.3.301. [DOI] [PubMed] [Google Scholar]
  46. Foil L.D., McManus J.M., Issel C.J. Estimation of the potential for mechanical transmission of pathogenic agents by Tabanus fuscicostatus (Diptera: Tabanidae) J. Med. Entomol. 1987;24:613–616. doi: 10.1093/jmedent/24.6.613. [DOI] [PubMed] [Google Scholar]
  47. Foil L.D., Adams W.V., McManus J.M., Issel C.J. Bloodmeal residues on mouthparts of Tabanus fuscicostatus (Diptera: Tabanidae) and the potential for mechanical transmission of pathogens. J. Med. Entomol. 1987;24:613–616. doi: 10.1093/jmedent/24.6.613. [DOI] [PubMed] [Google Scholar]
  48. Fujimiya Y., Perryman L.E., Crawford T.B. Leukocyte cytotoxicity in a persistent virus infection: presence of direct cytotoxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus. Inf. Immun. 1979;24:628–636. doi: 10.1128/iai.24.3.628-636.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Gendelman H.E., Narayan O., Molineaux S., Clements J.E., Ghotbi Z. Vol. 82. 1985. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow; pp. 7086–7090. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., Kennedy P.G.E., Ghotbi Z., Clements I.E., Stanley J., Pezeshkpour G. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J. Virol. 1986;58:67–74. doi: 10.1128/jvi.58.1.67-74.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Gerencer M., Valpotic I, Jukic B., Tomaskovic M, Basic I. Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS. Arch. Virol. 1989;104:249–257. doi: 10.1007/BF01315547. [DOI] [PubMed] [Google Scholar]
  52. Gollins S.W., Porterfield J.S. Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. J. Gen. Virol. 1984;65:1261–1272. doi: 10.1099/0022-1317-65-8-1261. [DOI] [PubMed] [Google Scholar]
  53. Gollins S.W., Porterfield J.S. Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. J. Gen. Virol. 1985;66:1969–1982. doi: 10.1099/0022-1317-66-9-1969. [DOI] [PubMed] [Google Scholar]
  54. Gonda M.A., Charman H.P., Walker J.L., Coggins L. Scanning and transmission electron microscopic study of equine infectious anemia virus. Am. J. Vet. Res. 1978;39:731–740. [PubMed] [Google Scholar]
  55. Goudsmit J., Houwers D.J., Smit L., Nauta I.M. LAV/HTLV-III gag gene product p24 shares antigenic determinants with equine infectious anemia virus but not with visna virus or caprine arthritis-encephalitis virus. Intervirology. 1986;26:169–173. doi: 10.1159/000149697. [DOI] [PubMed] [Google Scholar]
  56. Gutekunst D.R., Becvar C.S. Responses in horses infected with equine infectious anemia virus adapted to tissue culture. Am. J. Vet. Res. 1979;40:974–977. [PubMed] [Google Scholar]
  57. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476–481. doi: 10.1126/science.3277268. [DOI] [PubMed] [Google Scholar]
  58. Halstead S.B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Inf. Dis. 1979;140:527–533. doi: 10.1093/infdis/140.4.527. [DOI] [PubMed] [Google Scholar]
  59. Halstead S.B., O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 1977;265:739–741. doi: 10.1038/265739a0. [DOI] [PubMed] [Google Scholar]
  60. Harris J.D., Blum H., Scott J., Traynor B., Ventura P., Haase A. Vol. 81. 1984. Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA; pp. 7212–7215. (Proc. Natl. Acad. Sci. USA). [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Hasseltine W.A. Molecular biology of the human immunodeficiency virus type 1. FASEB J. 1991;5:2349–2360. doi: 10.1096/fasebj.5.10.1829694. [DOI] [PubMed] [Google Scholar]
  62. Hawkins J.A., Adams W.V., Cook L., Wilson B.H., Roth E.E. Role of horse fly (Tabanus fuscicostatus Hine) and stable fly (Stomoxys calcitrans L) in transmission of equine infectious anemia to ponies in Louisiana. Am. J. Vet. Res. 1973;34:1583–1586. [PubMed] [Google Scholar]
  63. Hawkins J.A., Adams W.V., Wilson B.H., Issel C.J., Roth E.E. Transmission of equine infectious anemia virus by Tabanus fuscicostatus. J. Am. Vet. Med. Assoc. 1976;168:63–64. [PubMed] [Google Scholar]
  64. Henderson L.E., Sowder R.C., Smythers G.W., Oroszlan S. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins. J. Virol. 1987;61:1116–1124. doi: 10.1128/jvi.61.4.1116-1124.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Henson J.B., McGuire T.C. Immunopathology of equine infectious anemia. Am. J. Clin. Pathol. 1971;56:306–314. doi: 10.1093/ajcp/56.3.306. [DOI] [PubMed] [Google Scholar]
  66. Homsy J., Meyer M., Tatano M., Clarkson S., Levy J.A. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science. 1989;244:1357–1360. doi: 10.1126/science.2786647. [DOI] [PubMed] [Google Scholar]
  67. Hussain K.A., Issel C.J., Schnorr K.L., Rwambo P.M., Montelaro R.C. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 1987;61:2956–2961. doi: 10.1128/jvi.61.10.2956-2961.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Hussain K.A., Issel C.J., Rwambo P.M., Arnizaut A.B., Ball J.M., Schnorr K.L., Montelaro R.C. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26. J. Gen. Virol. 1988;69:1719–1724. doi: 10.1099/0022-1317-69-7-1719. [DOI] [PubMed] [Google Scholar]
  69. Hussain K., Issel C.J., Schnorr K.L., Rwambo P.K., West M., Montelaro R.C. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Arch Virol. 1988;98:213–224. doi: 10.1007/BF01322170. [DOI] [PubMed] [Google Scholar]
  70. Inada T., Chong K.T., Mims C.A. Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J. Gen. Virol. 1985;66:871–878. doi: 10.1099/0022-1317-66-4-871. [DOI] [PubMed] [Google Scholar]
  71. Ishii S., Ishitani R. Equine infectious anemia. Adv. Vet. Sci. Comp. Med. 1975;19:195–222. [PubMed] [Google Scholar]
  72. Ishizaki R., Green R.W., Bolognesi D.P. The structural polypeptides of equine infectious anemia virus. Intervirology. 1978;9:286–294. doi: 10.1159/000148946. [DOI] [PubMed] [Google Scholar]
  73. Issel C.J., Adams W.V., Meek L., Ochoa R. Transmission of euqine infectious anemia virus from horses without clinical signs of disease. J. Am. Vet. Med Assoc. 1982;180:272–275. [PubMed] [Google Scholar]
  74. Issel C.J., Horohov D.W., Lea D.F., Adams W.V., Hagius S.D., McManus J.M., Allison A.C., Montelaro R.C. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 1992;66:3398–3408. doi: 10.1128/jvi.66.6.3398-3408.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Issel C.J., Foil L.D. Studies on equine infectious anemia virus transmission by insects. J. Am. Vet. Med. Assoc. 1984;184:293–297. [PubMed] [Google Scholar]
  76. Issel C.J., Adams W.V. Serologie survey for equine infectious anemia virus in Louisiana. J. Am. Vet. Med. Assoc. 1979;174:286–288. [PubMed] [Google Scholar]
  77. Issel C.J., Coggins L. Equine infectious anemia: Current knowledge. J. Am. Vet. Med. Assoc. 1979;174:727–733. [PubMed] [Google Scholar]
  78. Issel C.J., Rwambo P.M., Montelaro R.C. Evolution of eqine infectious anemia diagnostic tests: recognition of a need for detection of anti-EIAV glycoprotein antibodies. In: Powell E., editor. Equine Infectious Diseases V. Proceedings of the Fifth International Conference. University Press of Kentucky; Lexington, KY: 1988. pp. 196–200. [Google Scholar]
  79. Issel C.J., Cook R.F., Adams W.V., Foil L.D., McClure J.J., Haynes P.F., McClure J.R. Foetal responses to experimental infection with a cell-adapted strain of equine infectious anaemia virus. In: Plowright W., Rossdale P.D., Wade J.F., editors. Equine Infectious Diseases VI. Proceedings of the Sixth International Conference. R&W Publications; Newmarket: 1992. pp. 249–252. [Google Scholar]
  80. Jacks T., Madhani H.D., Masiarz F.R., Varmus H.E. Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell. 1988;55:447–458. doi: 10.1016/0092-8674(88)90031-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Jacks T., Power M.D., Masiarz F.R., Luciw P.A., Barr P.J., Varmus H.E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature. 1988;331:280–283. doi: 10.1038/331280a0. [DOI] [PubMed] [Google Scholar]
  82. Jacobse-Geels H.E.L., Daha M.R., Horzinek M.C. Antibody, immune complexes, and complement activity fluctuations in kittens with experimentally induced feline infectious peritonitis. Am. J. Vet. Res. 1982;43:666–670. [PubMed] [Google Scholar]
  83. Jolly P.E., Huso D.L., Sheffer D., Narayan O. Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding, internalization, and neutralization of visna virus in macrophages. J. Virol. 1989;63:1811–1813. doi: 10.1128/jvi.63.4.1811-1813.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S.R., Aaronson S.A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology. 1987;158:300–312. doi: 10.1016/0042-6822(87)90202-9. [DOI] [PubMed] [Google Scholar]
  85. Kemen M.J., McClain D.S., Matthysse J.G. Role of horse flies in transmission of equine infectious anemia from carrier ponies. J. Am. Vet. Med. Assoc. 1978;172:360–362. [PubMed] [Google Scholar]
  86. Kemen M.J., Coggins L. Equine infectious anemia: Transmission from infected mares to foals. J. Am. Vet. Med. Assoc. 1972;161:496–499. [PubMed] [Google Scholar]
  87. Kemeny L.J., Mott L.O., Pearson J.E. Titration of equine infectious anemia virus. Effect of dosage on incubation time and clinical signs. Cornell Vet. 1971;61:687–695. [PubMed] [Google Scholar]
  88. Kitano K., Abboud C.C., Ryan D.H., Quan S.G., Baldwin G.C., Golde D.W. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood. 1991;77:1699. [PubMed] [Google Scholar]
  89. Klevjer-Anderson P., Cheever W.P., Crawford T.B. Characterization of the infection of equine fibroblasts by equine infectious anemia virus. Arch. Virology. 1979;60:279–289. doi: 10.1007/BF01317499. [DOI] [PubMed] [Google Scholar]
  90. Kobayashi K., Kono Y. Propagation and titration of equine infectious anemia virus in horse leukocyte culture. Natl. Inst. Anim. Health Q. (Tokyo) 1967;6:8–20. [PubMed] [Google Scholar]
  91. Kono Y., Kobayashi K., Fukunaga Y. Distribution of equine infectious anemia virus in horses infected with the virus. Nat. Inst. Anim. Health Q. (Tokyo) 1971;11:11–20. [PubMed] [Google Scholar]
  92. Kono Y., Hirasawa K., Fukunaga Y., Taniguchi T. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inst. Anim. Health Q. (Tokyo) 1976;16:8–15. [PubMed] [Google Scholar]
  93. Kono Y., Yoshino T., Fukanaga Y. Growth characteristics of equine infectious anemia virus in horse leukocyte cultures. Arch. Virology. 1970;30:252–256. doi: 10.1007/BF01250196. [DOI] [PubMed] [Google Scholar]
  94. Kono Y., Yokomizo Y. Attempts to cultivate the equine infectious anemia virus in various types of cells. Natl. Inst. Anim. Health Q. (Tokyo) 1968;8:182–186. [PubMed] [Google Scholar]
  95. Kono Y., Kobayashi K. Specificity of assay of equine infectious anemia virus in horse leukocyte cultures. Natl. Inst. Anim. Health Q. (Tokyo) 1967;7:138–144. [PubMed] [Google Scholar]
  96. Kono Y. Proceedings, 3rd Internation Conf on Equine Infectious Diseases. Karger; Basel: 1973. Recurrences of equine infectious anemia; pp. 175–186. [Google Scholar]
  97. Kono Y., Kobayashi K., Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Virol. 1973;41:1–10. doi: 10.1007/BF01249923. [DOI] [PubMed] [Google Scholar]
  98. Kono Y., Sentsui H., Murakami Y. Development of specific in vitro lymphocyte stimulation responses in horses infected with equine infectious anaemia virus. Vet. Microbiol. 1976;1:31–43. [Google Scholar]
  99. Konno S., Yamamoto H. Pathology of equine infectious anemia. Proposed classification of pathologic types of disease. Cornell Vet. 1970;60:393–449. [PubMed] [Google Scholar]
  100. Leider J.M., Palese P., Smith F.I. Determination of the mutation rate of a retrovirus. J. Virol. 1988;62:3084–3091. doi: 10.1128/jvi.62.9.3084-3091.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Lignee M. Memoire et observations sur une maladie de sang, connue sous le nom d'anhemie hydrohemie cachexie aqueuse du cheval. Rec. Med. Vet. 1843;20:30. [Google Scholar]
  102. Malmquist W.A., Barnett D., Becvar C.S. Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Virol. 1973;42:361–370. doi: 10.1007/BF01250717. [DOI] [PubMed] [Google Scholar]
  103. Matheka H.D., Coggins L., Shively J.N., Norcross N.L. Purification and characterization of equine infectious anemia virus. Arch. Virol. 1976;51:107–114. doi: 10.1007/BF01317839. [DOI] [PubMed] [Google Scholar]
  104. Matsuda S., Gidlund M., Chiodi F., Catavo A., Nygren A., Morein B., Nilsson K., Fenyo E.M., Wigzell H. Enhancement of human immunodeficiency virus (HIV) replication in human monocytes by low titres of anti-HIV antibodies in vitro. Scand. J. Immunol. 1989;30:425–434. doi: 10.1111/j.1365-3083.1989.tb02446.x. [DOI] [PubMed] [Google Scholar]
  105. Matthias D.D., Schmidt D. On the pathogenesis of inclusion bodies (Heinz bodies) in equine infectious anemia. Arch. Exp. Vet. Med. 1956;10:257–274. [Google Scholar]
  106. McClure J.J., Lindsay W.A., Taylor W., Ochoa R., Issel C.J., Coulter S.J. Ataxia in four horses with equine infectious anemia. J. Am. Vet. Med. Assoc. 1982;180:279–283. [PubMed] [Google Scholar]
  107. McConnell M.B., Katada M., McConnell S., Moore R. Demonstration of equine infectious anemia virus in primary leukocyte cultures by electron microscopy. Am. J. Vet. Res. 1977;38:2067–2069. [PubMed] [Google Scholar]
  108. McGuire T.C., O'Rourke K., Cheevers W.P. A review of antigenic variation by the equine infectious anemia virus. Contr. Microbiol. Immunol. 1987;8:77–89. [PubMed] [Google Scholar]
  109. McGuire T.C. Animal Models of Retrovirus Infection and Their Relationship to AIDS. Academic Press; New York: 1986. Pathogenesis of equine infectious anemia; pp. 295–300. [Google Scholar]
  110. McGuire T.C., Henson J.B., Quist S.E. Viral-induced hemolysis in equine infectious anemia. Am. J. Vet. Res. 1969;30:2091–2097. [PubMed] [Google Scholar]
  111. McGuire T.C., Henson J.B., Burger D. Complement (C3)-coated red blood cells following infection with the virus of equine infectious anemia. J. Immunol. 1969;103:293–299. [PubMed] [Google Scholar]
  112. McGuire T.C., Perryman L.E., Henson J.B. Vol. 106. 1971. Immunoglobulin composition of the hypergammaglobulinemia of equine infectious anemia; p. 1074. (Fed. Proc.). (abstr). [Google Scholar]
  113. McGuire T.C., Henson J.B., Keown G.H. Equine infectious anemia. The role of Heinz bodies in the pathogenesis of anemia. Res. Vet. Sci. 1970;11:354–357. [PubMed] [Google Scholar]
  114. McGuire T.C., Crawford T.B., Henson J.B. Equine infectious anemia: detection of infectious virus-antibody complexes in the serum. Immunol. Commun. 1972;1:545–551. doi: 10.3109/08820137209022963. [DOI] [PubMed] [Google Scholar]
  115. McGuire T.C., Crawford T.B., Henson J.B. Immunofluorescent localization of equine infectious anemia virus in tissue. Am. J. Pathol. 1971;62:283–292. [PMC free article] [PubMed] [Google Scholar]
  116. McGuire T.C., Henson J.B., Quist S.E. Impaired bone marrow response in equine infectious anemia. Am. J. Vet. Res. 1969;30:2099–2104. [PubMed] [Google Scholar]
  117. McGuire T.C. Suppression of synthesis of an IgG subclass in a persistent viral infection. Immunol. 1976;30:17–24. [PMC free article] [PubMed] [Google Scholar]
  118. Montagnier L., Dauguet C., Axler C., Chamaret S., Gruest J., Nugeyre M.T., Rey F., Barre-Sinoussi F., Chermann J.C. A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: structural and antigenic relatedness with equine infecitous anaemia virus. Ann. Virol. 1984;135E:119–134. [Google Scholar]
  119. Montefiori D.C., Robinson W.E., Hirsch V.M., Modliszewski A., Mitchell W.M., Johnson P.R. Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected Rhesus macaques. J. Virol. 1990;64:113–119. doi: 10.1128/jvi.64.1.113-119.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Montelaro R.C., Robey W.G., West M.D., Issel C.J., Fischinger P.J. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J. Gen. Virol. 1988;69:1711–1717. doi: 10.1099/0022-1317-69-7-1711. [DOI] [PubMed] [Google Scholar]
  121. Montelaro R.C., Parekh B., Orrego A., Issel C.J. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 1984;259:10539–10544. [PubMed] [Google Scholar]
  122. Montelaro R.C., Lohrey N., Parekh B., Blakeney E.W., Issel C.J. Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus. J. Virol. 1982;42:1029–1038. doi: 10.1128/jvi.42.3.1029-1038.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Montelaro R.C., West M., Issel C.J. Antigenic reactivity of the major glycoprotein of equine infectious anemia virus, a retrovirus. Virology. 1984;136:368–374. doi: 10.1016/0042-6822(84)90173-9. [DOI] [PubMed] [Google Scholar]
  124. Muesing M.A., Smith D.H., Cabradilla C.K., Benton C.V., Lasky L.A., Capon D.J. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 1985;313:450–458. doi: 10.1038/313450a0. [DOI] [PubMed] [Google Scholar]
  125. Nishimura M., Nakajima H. Structural proteins of equine infectious anemia virus and their antigenic activity. Am. J. Vet. Res. 1984;45:5–10. [PubMed] [Google Scholar]
  126. Newman M.J., Issel C.J., Truax R.E., Powell M.D., Horohov D.W., Montelaro R. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV) Virol. 1991 doi: 10.1016/0042-6822(91)90821-r. [DOI] [PubMed] [Google Scholar]
  127. Noiman S., Yaniv A., Sherman L., Tronick S.R., Gazit A. Pattern of transcription of the genome of equine infectious anemia virus. J. Virol. 1990;64:1343–1839. doi: 10.1128/jvi.64.4.1839-1843.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Ochiai, H., Kurokawa, M., Hayashi, K. and Niwayama, S. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J. Virol. 62, 20–26. [DOI] [PMC free article] [PubMed]
  129. Orrego A., Issel C.J., Montelaro R.C., Adams W.V. Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am. J. Vet. Res. 1982;43:1556–1560. [PubMed] [Google Scholar]
  130. Oroszlan S., Gilden R. Primary structure analysis of retrovirus proteins. In: Stephenson J., editor. Molecular biology of RNA tumor viruses. Academic Press, Inc; New York: 1980. pp. 299–345. [Google Scholar]
  131. O'Rourke K.I., Besola M.L., McGuire T.C. Proviral sequences detected by polymerase chain reaction in peripheral blood cells of horses with equine infectious anemia lentivirus. Arch. Virol. 1991;117:109–119. doi: 10.1007/BF01310496. [DOI] [PubMed] [Google Scholar]
  132. O'Rourke K., Perryman L.E., McGuire T.C. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. J. Gen. Virol. 1988;69:667–674. doi: 10.1099/0022-1317-69-3-667. [DOI] [PubMed] [Google Scholar]
  133. O'Rourke K.I., Perryman L.E., McGuire T.C. Cross neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. Vet. Immunol. Immunopath. 1989;23:41–49. doi: 10.1016/0165-2427(89)90108-6. [DOI] [PubMed] [Google Scholar]
  134. Parekh B., Issel C.J., Montelaro R.C. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses. Virology. 1980;107:520–525. doi: 10.1016/0042-6822(80)90319-0. [DOI] [PubMed] [Google Scholar]
  135. Pauza C.D., Galindo J., Richman D.D. Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication. J. Virol. 1988;62:3558–3564. doi: 10.1128/jvi.62.10.3558-3564.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Payne S., Parekh B., Montelaro R.C., Issel C.J. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus. J. Gen. Virol. 1984;65:1395–1399. doi: 10.1099/0022-1317-65-8-1395. [DOI] [PubMed] [Google Scholar]
  137. Payne S.L., Fang F.D., Liu C.P., Dhruva B.R., Rwambo P., Issel C.J., Montelaro R.C. Antigenic variation and lentivirus persistence: variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV. Virology. 1987;161:321–331. doi: 10.1016/0042-6822(87)90124-3. [DOI] [PubMed] [Google Scholar]
  138. Payne S.L., Rushlow K., Dhruva B.R., Issel C.J., Montelaro R.C. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Virology. 1989;172:609–615. doi: 10.1016/0042-6822(89)90203-1. [DOI] [PubMed] [Google Scholar]
  139. Payne S.L., Salinovich O., Nauman S.M., Issel C.J., Montelaro R.C. Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J. Virol. 1987;61:1266–1270. doi: 10.1128/jvi.61.4.1266-1270.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Peiris J.S.M., Porterfield J.S. Antibody-mediated enhancement of flavivirus replication in macrophage-ike cell lines. Nature. 1979;282:509–511. doi: 10.1038/282509a0. [DOI] [PubMed] [Google Scholar]
  141. Perry S.T., Flaherty M.T., Kelley M.J., Clabough D.L., Tronick S.R., Coggins L., Whetter L., Lengel C.R., Fuller F. The surface envelope protein gene region of equine infectious anemia is not an important determinant of tropism in vitro. J. Virol. 1992;66:4085–4097. doi: 10.1128/jvi.66.7.4085-4097.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Perryman L.E., O'Rourke K.E., McGuire T.C. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 1988;62:3073–3076. doi: 10.1128/jvi.62.8.3073-3076.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Perryman L.E., McGuire T.C., Banks K.L., Henson J.B. Decreased C3 levels in a chronic virus infection: equine infectious anemia. J. Immunol. 1971;106:1074–1078. [PubMed] [Google Scholar]
  144. Rasty S., Dhruva B.R., Schütz R.L., Shih D.S., Issel C.J., Montelaro R.C. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections. J. Virol. 1990;64:86–95. doi: 10.1128/jvi.64.1.86-95.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Rice N.R., Lequarre A.S., Casey J.W., Lahn S., Stephens R.M., Edwards J. Viral DNA in horses infected with equine infectious anemia virus. J. Virol. 1989;63:5194–5200. doi: 10.1128/jvi.63.12.5194-5200.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Rice N.R., Henderson L.E., Sowder R.C., Copeland T.D., Oroszlan S., Edwards J.F. Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J. Virol. 1990;64:3770–3778. doi: 10.1128/jvi.64.8.3770-3778.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Rice N.R., Simek S., Ryder O.A., Coggins L. Detection of proviral DNA in horse cells infected with equine infectious anemia virus. J. Virol. 1978;26:577–583. doi: 10.1128/jvi.26.3.577-583.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Robinson W.E., Montefiori D.C., Mitchell W.M. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988;i:790–794. doi: 10.1016/s0140-6736(88)91657-1. [DOI] [PubMed] [Google Scholar]
  149. Rushlow K., Olsen K., Stiegler G., Payne S.L., Montelaro R.C., Issel C.J. Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology. 1986;155:309–321. doi: 10.1016/0042-6822(86)90195-9. [DOI] [PubMed] [Google Scholar]
  150. Rwambo P.M., Issel C.J., Adams W.V., Hussain K.A., Miller M., Montelaro R.C. Equine infectious anemia virus: humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 199;111:199–212. doi: 10.1007/BF01311054. [DOI] [PubMed] [Google Scholar]
  151. Salinovich O., Payne S.L., Montelaro R.C., Hussain K.A., Issel C.J., Schnorr K.L. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 1986;57:71–80. doi: 10.1128/jvi.57.1.71-80.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Saman E., Breugelmans K., Heyndrickx L., Merregaert J. The open reading frame ORF S3 of equine infectious anemia virus is expressed during the viral life cycle. J. Virol. 1990;64:6319–6324. doi: 10.1128/jvi.64.12.6319-6324.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Schlesinger J.J., Brandriss M.W. Growth of 17D yellow fever virus in a macrophage-like cell line, U937: role of Fc and viral receptors in antibody-mediated infection. J. Immunol. 1981;127:659–665. [PubMed] [Google Scholar]
  154. Sellon D.C., Perry S.T., Coggins L., Fuller F.J. Wild-type equine infectious anemia virus replicates in vivo predominanatly in mature tissue macrophages, not in peripheral blood lymphocytes. J. Virol. 1992;66:5906–5913. doi: 10.1128/jvi.66.10.5906-5913.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Sentsui H., Kono Y. Hemagglutination by equine infectious anemia virus. Inf. Immun. 1976;14:325–331. doi: 10.1128/iai.14.2.325-331.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Sentsui H., Kono Y. Complement-mediated hemolysis of horse erythrocytes treated with equine infectious anemia virus. Arch. Virol. 1987;95:53–66. doi: 10.1007/BF01311334. [DOI] [PubMed] [Google Scholar]
  157. Sentsui H., Kono Y. Mechanism of anemia in equine infectious anemia: virus and complement-mediated lysis and phagocytosis of horse erythrocytes. In: Powell D.G., editor. Equine Infectious Diseases V. Proceedings of the Fifth International Conference. University Press of Kentucky; Lexington, KY: 1988. pp. 251–257. [Google Scholar]
  158. Sentsui H., Kono Y. Phagocytosis of horse erythrocytes treated with equine infectious anemia virus by cultivated horse leukocytes. Arch. Virol. 1987;95:67–77. doi: 10.1007/BF01311335. [DOI] [PubMed] [Google Scholar]
  159. Shane B.S., Issel C.J., Montelaro R.C. Enzyme-linked immunosorbent assay for the detection of equine infectious anemia virus p26 antigen and antibody. J. Clin. Microbiol. 1984;19:351–355. doi: 10.1128/jcm.19.3.351-355.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Sherman L., Gazit A., Yaniv A., Kawakami T., Dahlberg J.E., Tronick S.R. Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat. J. Virol. 1988;62:120–126. doi: 10.1128/jvi.62.1.120-126.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Shively M.A., Banks K.L., Greenlee A., Klevjer-Anderson P. Antigenic stimulation of T-lymphocytes in chronic nononcogenic retrovirus infection: equine infectious anemia. Inf. Immun. 1982;36:38–46. doi: 10.1128/iai.36.1.38-46.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Stein C.D., Osteen O.S., Mott L.O. Experimental transmission of equine infectious anemia by contact and body secretions and excretions. Vet. Med. 1944;39:46–52. [Google Scholar]
  163. Stein C.D., Lotze J.C., Mott L.O. Transmission of equine infectious anemia by the stablefly, Stomoxys calcitrans, the horsefly, Tabanus sulcifrons (Macquart), and by injection of minute amounts of virus. Am. J. Vet. Res. 1942;3:183–193. [Google Scholar]
  164. Stephens R.M., Derse D., Rice N.R. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative rev proteins. J. Virol. 1990;64:3716–3725. doi: 10.1128/jvi.64.8.3716-3725.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Stephens R.M., Casey J.W., Rice N.R. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus. Science. 1986;231:589–594. doi: 10.1126/science.3003905. [DOI] [PubMed] [Google Scholar]
  166. Stowring L., Haase A.T., Charman H.P. Serological definition of the lentivirus group of retroviruses. J. Virol. 1979;29:523–528. doi: 10.1128/jvi.29.2.523-528.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Tajima M., Nakajima H., Ito Y. Electron microscopy of equine infectious anemia virus. J. Virol. 1969;4:521–527. doi: 10.1128/jvi.4.4.521-527.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Tashjian R.J. Transmission and clinical evaluation of an equine infectious anemia herd and their offspring over a 13-year period. J. Am. Vet. Med. Assoc. 1984;184:282–288. [PubMed] [Google Scholar]
  169. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., Perry S.T., Rushlow K.E., LeGrice S.F.J., Payne S.L. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J. Virol. 1993;67:2592–2600. doi: 10.1128/jvi.67.5.2592-2600.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Tremblay M., Meloche S., Sekaly R.P., Wainberg M.A. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells. J. Exp. Med. 1990;171:1791–1796. doi: 10.1084/jem.171.5.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Ushimi C., Henson J.B., Gorham J.R. Study of the one-step growth curve of equine infectious anemia virus by immunofluorescence. Inf. Immun. 1972;5:890–895. doi: 10.1128/iai.5.6.890-895.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Ushimi C., Nakajima H., Tanaka S. Demonstration of equine infectious anemia viral antigen by immunofluorescence. Natl. Inst. Anim. Health Q. (Tokyo) 1970;10:90–91. [PubMed] [Google Scholar]
  173. Van der Maaten M.J., Boothe A.D., Seger C.L. Isolation of a virus from cattle with persistent lymphocytosis. J. Natl. Cancer Inst. 1972;49:1649–1657. doi: 10.1093/jnci/49.6.1649. [DOI] [PubMed] [Google Scholar]
  174. Vennema H., de Groot R.J., Harbour D.A., Dalderup M., Gruffydd-Jones T., Horzinek M.C., Spaan W.J.M. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J. Virol. 1990;64:1407–1409. doi: 10.1128/jvi.64.3.1407-1409.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Veronese P.D.M., Copeland T.D., Oroszlan S., Gallo R.C., Sarngadharan M.G. Biochemical and mmunological analysis of human immunodeficiency virus gag gene products p 17 and p24. J. Virol. 1988;62:795–801. doi: 10.1128/jvi.62.3.795-801.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Weiland F., Matheka H.D., Coggins L., Hartner D. Electron microscopic studies on equine infectious anemia virus (EIAV) Arch. Virol. 1977;55:335–340. doi: 10.1007/BF01315055. [DOI] [PubMed] [Google Scholar]
  177. Weiss R.C., Scott F.W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immun. Microbiol. Infect. Dis. 1981;4:175–189. doi: 10.1016/0147-9571(81)90003-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Weiss R.C., Scott F.W. Pathogenesis of feline infectious peritonitis; nature and development of viremia. Am. J. Vet. Res. 1981;42:382–390. [PubMed] [Google Scholar]
  179. Weiss R.C., Scott F.W. Pathogenesis of feline infectious peritonitis: pathologic changes and immunofluorescence. Am. J. Vet. Res. 1981;42:2036–2048. [PubMed] [Google Scholar]
  180. Weiss R.C., Dodds W.J., Scott F.W. Disseminated intravascular coagulation in experimentally induced feline infectious peritonitis. Am. J. Vet. Res. 1980;41:663–671. [PubMed] [Google Scholar]
  181. Whetter L., Archambault D., Perry S., Gazit A., Coggins L., Yaniv A., Clabough D., Dahlberg J., Fuller F., Tronick S. Equine infectious anemia virus derived from a molecular clone persistently infects horses. J. Virol. 1990;64:5750–5756. doi: 10.1128/jvi.64.12.5750-5756.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Whitcomb J.M., Hughes S.H. The sequence of human immunodeficiency virus type 2 circle junction suggests that integration protein cleaves the ends of linear DNA asymmetrically. J. Virol. 1991;65:3906–3910. doi: 10.1128/jvi.65.7.3906-3910.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Yaniv A., Dahlberg J., Gazit A., Sherman L., Chiu I.M., Tronick S.R., Aaronson S.A. Molecular cloning and physical characterization of integrated equine infectious anemia virus: molecular and immunologie evidence of its close relationship to ovine and caprine lentiviruses. Virology. 1986;154:1–8. doi: 10.1016/0042-6822(86)90424-1. [DOI] [PubMed] [Google Scholar]

Articles from Virus Research are provided here courtesy of Elsevier

RESOURCES